How Healthcare M&A Firms Evaluate Growth vs Profit Tradeoffs Under Higher Cost of Capital
How Healthcare M&A Firms Evaluate Growth vs Profit Tradeoffs Under Higher Cost of Capital Key Takeaways Understanding the High Cost of Capital in Healthcare M&A In today’s healthcare market, rising interest rates and tighter lending conditions are reshaping the mergers and acquisitions landscape. Capital has become more expensive, and firms are no longer able to […]
Read More
What Sophisticated Buyers Expect From M&A Firms by 2026
What Sophisticated Buyers Expect From M&A Firms by 2026 Key Takeaways Why Buyer Expectations From M&A Firms Are Rapidly Changing Healthcare M&A has entered a fundamentally different era. Sophisticated buyers—private equity groups, DSOs, MSOs, and strategic operators—are no longer impressed by deal volume alone. By 2026, the question is not whether an M&A firm can […]
Read More
From Deal Execution to Enterprise Value Creation: The New Firm Mandate
From Deal Execution to Enterprise Value Creation: The New Firm Mandate Key Takeaways The Healthcare M&A Landscape Is Undergoing a Structural Shift For years, healthcare mergers and acquisitions have followed a familiar formula: grow revenue, stabilize EBITDA, hire a healthcare business broker, and take the asset to market. If the numbers looked attractive, a deal […]
Read More